Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders - PubMed (original) (raw)
Affiliations
- PMID: 9829013
Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders
D A Regier et al. Br J Psychiatry Suppl. 1998.
Abstract
Background: The co-occurrence of anxiety disorders with other mental, addictive, and physical disorders has important implications for treatment and for prediction of clinical course and associated morbidity.
Method: Cross-sectional and prospective data on 20,291 individuals from the Epidemiologic Catchment Area (ECA) study were analysed to determine one-month, current disorders, one-year incidence, and one-year and lifetime prevalence of anxiety, mood, and addictive disorders, and to identify the onset and offset of disorders within the one-year prospective period.
Results: Nearly half (47.2%) of those meeting lifetime criteria for major depression also have met criteria for a comorbid anxiety disorder. The average age of onset of any lifetime anxiety disorder (16.4 years) and social phobia (11.6 years) among those with major depression was much younger than the onset age for major depression (23.2 years) and panic disorder.
Conclusions: Anxiety disorders, especially social and simple phobias, appear to have an early onset in adolescence with potentially severe consequences, predisposing those affected to greater vulnerability to major depression and addictive disorders.
Similar articles
- McLean Hospital depression research facility: early-onset phobic disorders and adult-onset major depression.
Schatzberg AF, Samson JA, Rothschild AJ, Bond TC, Regier DA. Schatzberg AF, et al. Br J Psychiatry Suppl. 1998;(34):29-34. Br J Psychiatry Suppl. 1998. PMID: 9829014 - Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
Gum AM, King-Kallimanis B, Kohn R. Gum AM, et al. Am J Geriatr Psychiatry. 2009 Sep;17(9):769-81. doi: 10.1097/JGP.0b013e3181ad4f5a. Am J Geriatr Psychiatry. 2009. PMID: 19700949 - The prevalence of mood and anxiety disorders in Australian women.
Williams L, Jacka F, Pasco J, Henry M, Dodd S, Nicholson G, Kotowicz M, Berk M. Williams L, et al. Australas Psychiatry. 2010 Jun;18(3):250-5. doi: 10.3109/10398561003731155. Australas Psychiatry. 2010. PMID: 20482429 - Comorbidity of mood and anxiety disorders.
Kaufman J, Charney D. Kaufman J, et al. Depress Anxiety. 2000;12 Suppl 1:69-76. doi: 10.1002/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K. Depress Anxiety. 2000. PMID: 11098417 Review. - Epidemiology of anxiety disorders.
Kessler RC, Ruscio AM, Shear K, Wittchen HU. Kessler RC, et al. Curr Top Behav Neurosci. 2010;2:21-35. Curr Top Behav Neurosci. 2010. PMID: 21309104 Review.
Cited by
- Meeting report: "Depression and Anxiety Spectrum disorders: from basic science to the clinic and back".
Haber SN, Safadi Z, Milad MR. Haber SN, et al. Biol Mood Anxiety Disord. 2013 Mar 5;3(1):6. doi: 10.1186/2045-5380-3-6. Biol Mood Anxiety Disord. 2013. PMID: 23497694 Free PMC article. - Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?
Pani PP, Maremmani AG, Trogu E, Vigna-Taglianti F, Mathis F, Diecidue R, Kirchmayer U, Amato L, Ghibaudi J, Camposeragna A, Saponaro A, Davoli M, Faggiano F, Maremmani I. Pani PP, et al. Ann Gen Psychiatry. 2016 Apr 26;15:13. doi: 10.1186/s12991-016-0100-8. eCollection 2016. Ann Gen Psychiatry. 2016. PMID: 27118983 Free PMC article. - Large-Group One-Session Treatment: Feasibility in Highly Height Fearful Individuals and Predictors of Outcome.
Wannemueller A, Gruszka P, Chwalek S, Fröhlich S, Mulders M, Schaumburg S, Schöttes J, Wiederhold S, Margraf J. Wannemueller A, et al. Front Psychol. 2019 Oct 24;10:2411. doi: 10.3389/fpsyg.2019.02411. eCollection 2019. Front Psychol. 2019. PMID: 31749735 Free PMC article. - Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes.
Smith KS, Rudolph U. Smith KS, et al. Neuropharmacology. 2012 Jan;62(1):54-62. doi: 10.1016/j.neuropharm.2011.07.026. Epub 2011 Jul 27. Neuropharmacology. 2012. PMID: 21810433 Free PMC article. Review. - Cognitive Deficits Are Attenuated in Neuroglobin Overexpressing Mice Exposed to a Model of Obstructive Sleep Apnea.
Nair D, Ramesh V, Gozal D. Nair D, et al. Front Neurol. 2018 Jun 5;9:426. doi: 10.3389/fneur.2018.00426. eCollection 2018. Front Neurol. 2018. PMID: 29922222 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous